Sample,Gene Name,Genotype,Phenotype
N1DL9171,CYP2B6,*1/*9,Intermediate Metabolizer
N1DL9171,DPYD,Reference/c.1627A>G (*5),Normal Metabolizer
N1DL9171,CYP3A4,*1/*1,Indeterminate
N1DL9171,NUDT15,*3/*3,Poor Metabolizer
N1DL9171,IFNL3,Reference/rs12980275,Indeterminate
N1DL9171,ABCG2,Reference/rs2231142,Decreased Function
N1DL9171,CYP2C9,*1/*1,Normal Metabolizer
N1DL9171,CYP2C8,*1/*1,Indeterminate
N1DL9171,NAT2,*6/*6,Indeterminate
N1DL9171,VKORC1,Reference/Reference,Indeterminate
N1DL9171,G6PD,B/B,Indeterminate
N1DL9171,SLCO1B1,*1/*37,Normal Function
N1DL9171,CACNA1S,Reference/Reference,Uncertain Susceptibility
N1DL9171,CYP2D6,*2/*2,Normal Metabolizer
N1DL9171,CYP2C19,*1/*3,Intermediate Metabolizer
N1DL9171,UGT1A1,*1/*6,Intermediate Metabolizer
N1DL9171,F5,Reference/Reference,Favorable Response
N1DL9171,RYR1,Reference/Reference,Uncertain Susceptibility
N1DL9171,CFTR,Reference/Reference,Indeterminate
N1DL9171,TPMT,*1/*1,Normal Metabolizer
N1DL9171,CYP3A5,*1/*3,Intermediate Metabolizer
N1DL9171,CYP4F2,*1/*3,Indeterminate
